Wearables and Biologics Push Care Beyond the Clinic

US firms pioneer wearable and greener drug-delivery systems as biologics reshape patient care

13 Oct 2025

A quiet revolution is taking shape beyond hospital walls. As demand for biologic medicines surges, American drug-delivery firms are pushing treatment closer to patients’ homes. Recent regulatory approvals, corporate partnerships and facility expansions suggest a steady shift toward at-home biologic therapy, though the transition remains incomplete.

Leading the movement is wearable technology. Enable Injections, based in Cincinnati, has broadened global access to its enFuse device after approvals in Brazil and Britain. The system lets patients self-administer large biologic doses beneath the skin. “This is not just a device story; it’s a healthcare transformation,” said one analyst. Such technology promises greater convenience and safety, and is prompting drugmakers to rethink their commercial strategies.

Innovation is not confined to wearables. Kindeva Drug Delivery recently opened a new British facility to develop low-emission inhaler propellants, aligning product design with environmental goals. Catalent, now privately held, is expected to focus more heavily on biologics and gene therapies, while keeping a hand in other dosage forms. Its restructuring hints at a more agile business model in a fast-changing market.

The unifying theme is efficiency. Pharmaceutical companies are partnering with specialist delivery firms to accelerate development, strengthen safety, and improve patient adherence. Yet obstacles remain. Regulatory complexity, reimbursement limits and the need for patient training could all delay wider adoption.

Still, momentum is building. As biologics and gene therapies take up a growing share of drug pipelines, so too does the need for delivery systems that are portable, sustainable and easy to use. From discreet wearable injectors to eco-friendly inhalers, the next wave of pharmaceutical innovation is bringing treatment out of clinics and into living rooms.